Drug
Csl312
Csl312: highest development phase Phase 3, developed by CSL. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- CSL
Trials
| Drug | Phase | Indication |
|---|---|---|
| CSL312 NCT04739059 | Phase 3 | Hereditary Angioedema |
| CSL312 NCT04656418 | Phase 3 | Hereditary Angioedema |
Latest
No recent events.
Follow Csl312 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.